Ipilimumab/nivolumabHypophysitis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1847卷 / 1期

关键词：

D O I：

10.1007/s40278-021-92816-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：259 / 259

相关论文

共 50 条

[1] Ipilimumab/nivolumabHypophysitis: case report
[J]. Reactions Weekly, 2023, 1965 (1) : 258 - 258
[2] Ipilimumab/nivolumabHypophysitis: case report
[J]. Reactions Weekly, 2022, 1887 (1) : 396 - 396
[3] Ipilimumab/nivolumabHypophysitis: case report
[J]. Reactions Weekly, 2022, 1926 (1) : 277 - 277
[4] Ipilimumab/nivolumabHypophysitis: case report
[J]. Reactions Weekly, 2021, 1843 (1) : 210 - 210
[5] Ipilimumab/nivolumabHypophysitis: case report
[J]. Reactions Weekly, 2019, 1748 (1) : 266 - 266
[6] Ipilimumab/nivolumabHypophysitis: case report
[J]. Reactions Weekly, 2019, 1747 (1) : 159 - 159
[7] Ipilimumab/nivolumabHypophysitis: case report
[J]. Reactions Weekly, 2023, 1954 (1) : 261 - 261
[8] Ipilimumab/nivolumabHypophysitis and hypopituitarism: case report
[J]. Reactions Weekly, 2021, 1837 (1) : 364 - 364
[9] Ipilimumab/nivolumabHypophysitis and hypothyroidism: case report
[J]. Reactions Weekly, 2018, 1696 (1) : 215 - 215
[10] Ipilimumab/nivolumabHypophysitis and endocrinopathies: case report
[J]. Reactions Weekly, 2020, 1800 (1) : 176 - 176

← 1 2 3 4 5 →